全文获取类型
收费全文 | 2318篇 |
免费 | 111篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 131篇 |
妇产科学 | 27篇 |
基础医学 | 193篇 |
口腔科学 | 72篇 |
临床医学 | 189篇 |
内科学 | 547篇 |
皮肤病学 | 26篇 |
神经病学 | 109篇 |
特种医学 | 267篇 |
外科学 | 237篇 |
综合类 | 85篇 |
一般理论 | 4篇 |
预防医学 | 246篇 |
眼科学 | 35篇 |
药学 | 82篇 |
中国医学 | 1篇 |
肿瘤学 | 180篇 |
出版年
2022年 | 13篇 |
2021年 | 21篇 |
2020年 | 12篇 |
2019年 | 17篇 |
2018年 | 27篇 |
2017年 | 19篇 |
2016年 | 28篇 |
2015年 | 27篇 |
2014年 | 45篇 |
2013年 | 48篇 |
2012年 | 100篇 |
2011年 | 71篇 |
2010年 | 62篇 |
2009年 | 63篇 |
2008年 | 92篇 |
2007年 | 109篇 |
2006年 | 117篇 |
2005年 | 99篇 |
2004年 | 100篇 |
2003年 | 78篇 |
2002年 | 50篇 |
2001年 | 71篇 |
2000年 | 66篇 |
1999年 | 65篇 |
1998年 | 64篇 |
1997年 | 76篇 |
1996年 | 53篇 |
1995年 | 54篇 |
1994年 | 62篇 |
1993年 | 65篇 |
1992年 | 42篇 |
1991年 | 35篇 |
1990年 | 33篇 |
1989年 | 64篇 |
1988年 | 61篇 |
1987年 | 49篇 |
1986年 | 40篇 |
1985年 | 45篇 |
1984年 | 27篇 |
1983年 | 34篇 |
1982年 | 25篇 |
1981年 | 23篇 |
1980年 | 26篇 |
1979年 | 16篇 |
1978年 | 15篇 |
1977年 | 17篇 |
1976年 | 15篇 |
1975年 | 20篇 |
1974年 | 10篇 |
1971年 | 7篇 |
排序方式: 共有2433条查询结果,搜索用时 15 毫秒
81.
Baumgartner C; Morell A; Hirt A; Bucher U; Forster HK; Doran JE; Matter L; Brun del Re G; Wagner HP 《Blood》1988,71(5):1211-1217
Elimination of neoplastic B cell populations from autologous bone marrow grafts also removes normal B lymphocytes. This is potentially hazardous for the reconstitution of the immune system in patients undergoing high-dose chemotherapy and total body irradiation followed by autologous marrow rescue. Five pediatric patients with B cell non- Hodgkin's lymphoma in first remission undergoing such a regimen were studied. They received bone marrow pretreated with anti-Y 29/55 monoclonal antibody and complement. B and T lymphocyte subpopulations reached normal levels within 6 months after autologous bone marrow transplantation (ABMT), and serum immunoglobulin levels became normal within 4 to 9 months. Vaccination with diphtheria and tetanus toxoid, trivalent poliomyelitis vaccine of the Salk type, and pneumococcal capsular antigens (38 to 54 months after transplantation) gave rise to specific antibody production. ABO isoagglutinins could be demonstrated in all patients. The response pattern was similar to that of patients who received unmanipulated autologous bone marrow. It is concluded that ex vivo anti-Y 29/55 depletion of the marrow graft does not induce relevant disturbances of humoral immune functions. 相似文献
82.
Aladdin H. Shadyab PhD JoAnn E. Manson MD DrPH Juhua Luo PhD Bernhard Haring MD MPH Nazmus Saquib PhD Linda G. Snetselaar RD PhD LD Jiu-Chiuan Chen MD ScD Erik J. Groessl PhD Sylvia Wassertheil-Smoller PhD Yangbo Sun MD PhD Lauren Hale PhD Meryl S. LeBoff MD Andrea Z. LaCroix PhD 《Journal of the American Geriatrics Society》2020,68(9):1970-1978
83.
J. M. Paik G. C. Curhan Q. Sun K. M. Rexrode J. E. Manson E. B. Rimm E. N. Taylor 《Osteoporosis international》2014,25(8):2047-2056
Summary
Some recent reports suggest that calcium supplement use may increase risk of cardiovascular disease. In a prospective cohort study of 74,245 women in the Nurses' Health Study with 24 years of follow-up, we found no independent associations between supplemental calcium intake and risk of incident coronary heart disease (CHD) and stroke.Introduction
Some recent reports suggest that calcium supplements may increase cardiovascular disease (CVD) risk. The objective was to examine the independent associations between calcium supplement use and risk of CVD.Methods
We conducted a prospective cohort study of supplemental calcium use and incident CVD in 74,245 women in the Nurses' Health Study (1984–2008) free of CVD and cancer at baseline. Calcium supplement intake was assessed every 4 years. Outcomes were incident CHD (nonfatal or fatal MI) and stroke (ischemic or hemorrhagic), confirmed by medical record review.Results
During 24 years of follow-up, 4,565 cardiovascular events occurred (2,709 CHD and 1,856 strokes). At baseline, women who took calcium supplements had higher levels of physical activity, smoked less, and had lower trans fat intake compared with those who did not take calcium supplements. After multivariable adjustment for age, body mass index, dietary calcium, vitamin D intake, and other CVD risk factors, the relative risk of CVD for women taking >1,000 mg/day of calcium supplements compared with none was 0.82 (95 % confidence interval [CI] 0.74 to 0.92; p for trend <0.001). For women taking >1,000 mg/day of calcium supplements compared with none, the multivariable-adjusted relative risk for CHD was 0.71 (0.61 to 0.83; p for trend?<?0.001) and for stroke was 1.03 (0.87 to 1.21; p for trend?=?0.61). The relative risks were similar in analyses limited to non-smokers, women without hypertension, and women who had regular physical exams.Conclusions
Our findings do not support the hypothesis that calcium supplement intake increases CVD risk in women. 相似文献84.
Karen A. Ertel Marushka Silveira Penelope Pekow Barry Braun JoAnn E. Manson Caren G. Solomon Glenn Markenson Lisa Chasan-Taber 《Archives of women's mental health》2014,17(1):65-72
The aim of this study is to prospectively examine the association between maternal depressive symptoms in early pregnancy and risk of abnormal glucose tolerance (AGT) and impaired glucose tolerance (IGT) in mid-pregnancy. We evaluated this association among 934 participants in Proyecto Buena Salud, a prospective cohort study of Hispanic (predominantly Puerto Rican) women in Western Massachusetts. Depressive symptoms were assessed in early pregnancy using the 10-item Edinburgh Postnatal Depression Scale. Scores ≥13 indicated at least probable minor depression and scores ≥15 indicated probable major depression. AGT and IGT were diagnosed using American Diabetes Association criteria. In early pregnancy, 247 (26.5 %) participants experienced at least minor depression and 163 (17.4 %) experienced major depression. A total of 123 (13.2 %) were classified with AGT and 56 (6.0 %) were classified with IGT. In fully-adjusted models, the odds ratio for AGT associated with minor depression was 1.20 (95 % CI 0.77–1.89) and for major depression was 1.34 (95 % CI 0.81–2.23). The odds ratio for IGT associated with minor depression was 1.22 (95 % CI 0.62–2.40) and for major depression was 1.53 (95 % CI 0.73–3.22). We did not observe an association with continuous screening glucose measures. Findings in this prospective cohort of Hispanic women did not indicate a statistically significant association between minor or major depression in early pregnancy and AGT or screening glucose values in mid-pregnancy. Due to the small number of cases of IGT, our ability to evaluate the association between depression and IGT risk was constrained. 相似文献
85.
Xinhui Wang Diana Younan Joshua Millstein Andrew J. Petkus Erika Garcia Daniel P. Beavers Mark A. Espeland Helena C. Chui Susan M. Resnick Margaret Gatz Joel D. Kaufman Gregory A. Wellenius Eric A. Whitsel JoAnn E. Manson Stephen R. Rapp Jiu-Chiuan Chen 《Proceedings of the National Academy of Sciences of the United States of America》2022,119(2)
Late-life ambient air pollution is a risk factor for brain aging, but it remains unknown if improved air quality (AQ) lowers dementia risk. We studied a geographically diverse cohort of older women dementia free at baseline in 2008 to 2012 (n = 2,239, aged 74 to 92). Incident dementia was centrally adjudicated annually. Yearly mean concentrations of fine particulate matter (PM2.5) and nitrogen dioxide (NO2) were estimated using regionalized national universal kriging models and averaged over the 3-y period before baseline (recent exposure) and 10 y earlier (remote exposure). Reduction from remote to recent exposures was used as the indicator of improved AQ. Cox proportional hazard ratios (HRs) for dementia risk associated with AQ measures were estimated, adjusting for sociodemographic, lifestyle, and clinical characteristics. We identified 398 dementia cases during follow up (median = 6.1 y). PM2.5 and NO2 reduced significantly over the 10 y before baseline. Larger AQ improvement was associated with reduced dementia risks (HRPM2.5 0.80 per 1.78 μg/m3, 95% CI 0.71–0.91; HRNO2 0.80 per 3.91 parts per billion, 95% CI 0.71–0.90), equivalent to the lower risk observed in women 2.4 y younger at baseline. Higher PM2.5 at baseline was associated with higher dementia risk (HRPM2.5 1.16 per 2.90 μg/m3, 95% CI 0.98–1.38), but the lower dementia risk associated with improved AQ remained after further adjusting for recent exposure. The observed associations did not substantially differ by age, education, geographic region, Apolipoprotein E e4 genotypes, or cardiovascular risk factors. Long-term AQ improvement in late life was associated with lower dementia risk in older women.Consistent evidence from epidemiologic studies and toxicological experiments has shown that ambient air pollution is an important modifiable risk factor of dementia (1). Several studies have shown an increased risk of dementia associated with late-life exposures to regional fine particulate matter (PM2.5; with aerodynamic diameter < 2.5 μm) (2–15) and gaseous pollutants (e.g., NO2; NOx) (2–4, 11, 12, 15–17) in particular. Over the past 50 y, significant improvements in air quality (AQ) have been observed across the United States because of national policies and strategies aimed at regulating pollution from stationary (power plants; factories) and mobile (vehicles) sources (18). Several US studies have shown that these long-term reductions in air pollution levels are associated with improved lung function (19), decreased bronchitic symptoms (20), lower asthma incidence (21), lengthened life expectancy (22), and reduced mortality (23). However, it remains unclear whether improved AQ also benefits the aging brains.Therefore, we conducted a multiyear study to examine the association between improved AQ and incidence of dementia, which was based on Diagnostic and Statistical Manual of Mental Disorders (Fourth edition) criteria and centrally adjudicated annually (24, 25). We examined data from the Women’s Health Initiative (WHI) Memory Study (WHIMS)—Epidemiology of Cognitive Health Outcomes (WHIMS-ECHO) that included a combined 20 y of data on individual-level outdoor air pollution (1998 to 2012) estimated using regionalized national universal kriging models (26–28) and cognitive function assessed annually (2008 to 2018) in a geographically diverse sample of community-dwelling older women in the United States. We hypothesized that improved AQ over the span of 10 y, as indicated by reductions in PM2.5 and NO2 (proxy for traffic pollutants), was associated with lower dementia risk. 相似文献
86.
87.
幽门螺杆菌cagⅡ对胃上皮细胞IL-8基因转录的影响及机制 总被引:6,自引:0,他引:6
目的探讨HpcagⅡ对胃上皮细胞IL-8基因转录的影响及信号传导机制。方法构建
cagⅡ基因位点缺失Hp突变株及带有IL-8报告基因的人胃癌细胞系L5F11,用液体闪烁计数仪测定荧光素酶(IL8转录)活性,用ELISA法测定IL8蛋白浓度。结果所有Hp突变株诱导荧光素酶活性与IL8蛋白浓度较亲代菌株26695均降低[(0.13±0.01)×cpm比(0.59±0.05)×(P<0.01);(0.73±0.13)ng/ml比(2.22±0.65)ng/ml,(P<0.05)]。PTK抑制剂herbimycinA不仅抑制Hp诱导的荧光素酶活性[(0.71±0.18)×cpm比(1.51±0.23)×cpm,(P<0.05)],而且抑制IL-8蛋白表达[(0.83±0.41)ng/ml比(3.22±0.59)ng/ml,(P<0.05)],但herbimycinA对TNFα诱导的荧光素酶活性及IL8蛋白表达均无影响(P均>0.05);PKA抑制剂H7抑制TNFα诱导的荧光素酶活性[(0.74±0.16)×cpm比(2.62±0.26)×cpm,(P<0.001)]及IL8蛋白表达[(1.45±0.38)ng/ml比(4.12±0.43)ng/ml,(P<0.01)],而对Hp诱导的荧光素酶活性无影响(P>0.05)。结论HpcagⅡ中的多基因能够调节胃上皮细胞IL-8基因转录,且这一作用主要经蛋白酪氨酸激酶途径。 相似文献
88.
Prichard HL Manson RJ DiBernardo L Niklason LE Lawson JH Dahl SL 《Journal of cardiovascular translational research》2011,4(5):674-682
Intimal hyperplasia is one of the prominent failure mechanisms for arteriovenous fistulas and arteriovenous access grafts.
Human tissue-engineered vascular grafts (TEVGs) were implanted as arteriovenous grafts in a novel baboon model. Ultrasound
was used to monitor flow rates and vascular diameters throughout the study. Intimal hyperplasia in the outflow vein of TEVGs
was assessed at the anastomosis and at juxta-anastomotic regions via histological analysis, and was compared to intimal hyperplasia
with polytetrafluoroethylene (PTFE) grafts in the baboon model and in literature reports from other animal models. Less venous
intimal hyperplasia was observed in histological sections with arteriovenous TEVGs than with arteriovenous PTFE grafts. TEVGs
were associated with a mild, noninflammatory intimal hyperplasia. The extent of intimal tissue that formed with TEVG placement
correlated with the rate of blood flow through tissue engineered vascular grafts at 2 weeks postimplant. Outflow vein dilatation
was observed with increased flow rate. Both mid-graft flow rates and outflow vein diameters reached a plateau by week 4, which
suggested that venous remodeling and intimal hyperplasia largely occurred within the first 4 weeks of implant in the baboon
model. Given their compliant and noninflammatory nature, TEVGs appear resistant to triggers for venous intimal hyperplasia
that are common for PTFE arteriovenous grafts, including (1) abundant proinflammatory macrophage populations that are associated
with PTFE grafts and (2) compliance mismatch between PTFE grafts and the outflow vein. Our findings suggest that arteriovenous
TEVGs develop only a mild form of venous intimal hyperplasia, which results from the typical hemodynamic changes that are
associated with arteriovenous settings. 相似文献
89.
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection. 总被引:7,自引:4,他引:7 下载免费PDF全文
D McMahon-Pratt D Rodriguez J R Rodriguez Y Zhang K Manson C Bergman L Rivas J F Rodriguez K L Lohman N H Ruddle et al. 《Infection and immunity》1993,61(8):3351-3359
Leishmania is a genus of parasitic protozoa capable of causing a spectrum of human diseases. The GP46/M-2 membrane glycoprotein has been demonstrated in a murine model system to elicit a protective immune response against infection with Leishmania amazonensis; in highly susceptible BALB/c mice, immunization leads to significant protection against infection. In the present study, for induction of long-term immunological effects, two recombinant vaccinia viruses, derived from the wild type and attenuated variant 48-7 and expressing the GP46/M-2 protein, were constructed; to ensure safety, we used the attenuated vaccinia virus mutant (48-7) as a live vector. Susceptible BALB/c mice immunized with either GP46/M-2-recombinant vaccinia virus were significantly protected against infection with L. amazonensis; 45 to 76% of the animals were completely protected (sterile) against a challenge inoculum of 10(3) infective organisms. The protectively immunized animals demonstrated T- and B-cell-dependent immunological responses; both lymphokine responses as well as antibody responses and long-term memory are indicative of T-cell activation. This first report of the use of a recombinant vaccinia virus to induce protection against a Leishmania infection indicates that recombinant vaccinia viruses should be of value in the design of a safe and effective vaccine against this parasitic disease. 相似文献
90.
Cytokine production by primary bone marrow megakaryocytes 总被引:4,自引:2,他引:4
Primary human bone marrow megakaryocytes were studied for their ability to express and release cytokines potentially relevant to their proliferation and/or differentiation. The purity of the bone marrow megakaryocytes was assessed by morphologic and immunocytochemical criteria. Unstimulated marrow megakaryocytes constitutively expressed genes for interleukin-1 beta (IL-1 beta), IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-alpha (TNF-alpha), by the polymerase chain reaction (PCR) and Northern blot analysis. At the protein level, megakaryocytes secreted significant amounts of IL-1 beta (53.6 +/- 3.6 pg/mL), IL-6 (57.6 +/- 15.6 pg/mL), and GM-CSF (24 +/- 4 pg/mL) but not TNF-alpha. Exposure of human marrow megakaryocytes to IL-1 beta increased the levels of IL-6 (87.3 +/- 2.3 pg/mL) detected in the culture supernatants. Transforming growth factor- beta was also able to stimulate IL-6, IL-1 beta, and GM-CSF secretion, but was less potent than stimulation with phorbol-12-myristate-13- acetate (PMA). The secreted cytokines acted additively to maintain and increase the number of colony-forming unit-megakaryocytes colonies (approximately 35%). These studies demonstrate the production of multiple cytokines by isolated human bone marrow megakaryocytes constitutively or stimulated in vitro. The capacity of human megakaryocytes to synthesize several cytokines known to modulate hematopoietic cells supports the concept that there may be an autocrine mechanism operative in the regulation of megakaryocytopoiesis. 相似文献